Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 641 | $45.80 | $29,355.56 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,681 | $39.50 | $263,906.85 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 72,130 | $42.50 | $3,065,366.31 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,610 | $52.65 | $137,416.50 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,210 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $52.64 | $42,112.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,820 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 14,700 | $52.63 | $773,661.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $52.62 | $15,786.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,320 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,000 | $52.61 | $157,830.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,500 | $52.60 | $604,900.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,800 | $52.59 | $357,612.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,120 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,000 | $52.58 | $210,320.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,920 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $52.57 | $26,285.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,920 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,200 | $52.56 | $115,632.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,420 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $52.54 | $5,254.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $52.53 | $31,518.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,720 Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 219,192 | $0.00 Strike: $52.39 | $0.00 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · derivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,192 Underlying: common shares · 219,192 shares Expires 2013-02-13 F3 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 281,530 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · derivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,705 Underlying: common shares · 281,530 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 219,192 | $52.39 | $11,483,468.88 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,758 Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 281,530 | $33.23 | $9,355,636.04 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2007 Filed Mar 28, 2007 19:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,288 | $57.24 | $188,205.12 |
DisclosureSEC source: 0001104659-07-023100 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,420 Read SEC document |
| March 01, 2007 Filed Mar 28, 2007 19:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-023100 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,708 Read SEC document |
| February 20, 2007 Filed Feb 20, 2007 21:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 15,780 | $52.49 | $828,292.20 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,124 Read SEC document |
| February 18, 2007 Filed Feb 20, 2007 21:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,101 | $52.49 | $320,241.49 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,904 Read SEC document |
| February 17, 2007 Filed Feb 20, 2007 21:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 13,151 | $52.49 | $690,295.99 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,005 Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 302,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · derivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,000 Underlying: common shares · 302,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 100,667 on 2/16/08, 100,667 on 2/16/09 and 100,666 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 125,000 | $52.54 | $6,567,500.00 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,156 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 21:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 57,203 | $52.70 | $3,014,598.10 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,156 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,144 | $0.00 Strike: $51.06 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,144 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,142 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,142 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 20,702 | $0.00 Strike: $45.80 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 20,702 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 23,988 | $53.03 | $1,271,978.09 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,359 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,144 | $51.06 | $58,411.95 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,142 | $46.65 | $99,924.30 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 20,702 | $45.80 | $948,079.14 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 20,839 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,839 Underlying: common shares · 20,839 shares Expires 2010-07-31 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 21,357 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,357 Underlying: common shares · 21,357 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 25,240 | $0.00 Strike: $39.50 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,681 Underlying: common shares · 25,240 shares Expires 2010-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 25,298 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 25,298 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 42,196 | $52.55 | $2,217,399.80 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,359 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 25,240 | $39.50 | $997,007.76 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 25,298 | $40.95 | $1,035,879.74 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2006 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,017 Read SEC document |
| November 29, 2006 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,307 Read SEC document |
| October 27, 2006 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 945 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,627 Read SEC document |
| June 05, 2006 Filed Jun 7, 2006 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,666 | $42.68 | $327,184.88 |
DisclosureSEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 7,600 F1 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife. Read SEC document |
| June 05, 2006 Filed Jun 7, 2006 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 25,000 | $42.93 | $1,073,125.00 |
DisclosureSEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,572 Read SEC document |
| June 05, 2006 Filed Jun 7, 2006 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 25,000 | $42.79 | $1,069,625.00 |
DisclosureSEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,572 Read SEC document |
| June 05, 2006 Filed Jun 7, 2006 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 734 | $42.72 | $31,356.48 |
DisclosureSEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,572 Read SEC document |
| May 09, 2006 Filed Jun 7, 2006 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,306 Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 18:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 71,191 | $0.00 Strike: $42.64 | $0.00 |
DisclosureSEC source: 0001104659-06-022078 · a4.xml · derivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,191 Underlying: common shares · 71,191 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.